Filing Details
- Accession Number:
- 0001125345-25-000031
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-19 16:23:17
- Reporting Period:
- 2025-02-15
- Filing Date:
- 2025-02-19
- Accepted Time:
- 2025-02-19 16:23:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1125345 | Macrogenics Inc | MGNX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2051299 | Ann Beth Smith | 9704 Medical Center Drive Rockville MD 20850 | Vp, Controller & Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-15 | 1,095 | $0.00 | 9,955 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-15 | 423 | $2.56 | 9,532 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit | Disposition | 2025-02-15 | 1,095 | $0.00 | 1,095 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,095 | No | 4 | M | Direct |
Footnotes
- On February 15, 2023 the reporting person was granted 3,285 restricted stock units, 33% of which vested on February 15, 2024 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
Billionaire Hedge Funds
